Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crowdstrike Holdings Inc (CRWD) vs Enveric Biosciences Inc (ENVB) Price & Performance

Crowdstrike Holdings IncTrade
Enveric Biosciences IncTrade

Price performance (Past 24H)

Key statistics

Crowdstrike Holdings Inc vs Enveric Biosciences Inc — how do they compare? Crowdstrike Holdings Inc trades at $220.33 (market cap $225.95B), while Enveric Biosciences Inc trades at $1.45 (market cap $6.20M). The key difference: Crowdstrike Holdings Inc is far larger — about 36443.5× Enveric Biosciences Inc's market cap, and Crowdstrike Holdings Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.

CRWDENVB
Market Cap
$225.95B$6.20M
Sector
TechnologyHealth
52-Week High
$225.16$17.40
52-Week Low
$87.56$1.27
Enterprise Value
$222.22B$1.30M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Crowdstrike Holdings Inc

No Aura AI signal available yet.

Enveric Biosciences Inc

ENVB trades at $1.55, down 0.64% with a bullish technical signal despite negative profitability. The company shows promising clinical progress with its lead candidate EB-003, supported by recent FDA guidance and positive preclinical data. While quarterly earnings consistently beat expectations, the company remains unprofitable with negative ROE and ROA. Analyst sentiment is positive with 75% buy ratings.

Investment outlook hinges on successful drug development milestones, with regulatory progress and intellectual property expansion providing catalysts. Key risks include clinical trial outcomes, cash burn from operations, and dependence on financing activities. The stock presents speculative growth potential for risk-tolerant investors focused on biotech innovation.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Crowdstrike Holdings Inc

CrowdStrike Holdings provides cybersecurity products and services aimed at protecting organizations from cyberthreats. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, identity protection, and log management. CrowdStrike went public in 2019 and serves customers worldwide.

Read more on CRWD

About Enveric Biosciences Inc

Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.

Read more on ENVB